Objectives: We aimed to review the literature linking metabolic factors to Diffuse Idiopathic Skeletal Hyperostosis (DISH), in order to assess associations between growth factors and DISH.
INTRODUCTION
Diffuse idiopathic skeletal hyperostosis (DISH) is a common skeletal disorder characterised by the presence of new bone formation. The new bone is particularly prominent in entheseal areas, where ligaments, tendons, joint capsule and annulus fibrosis fibres insert into bone. In addition, there is also an increase in the amount of normal cancellous and cortical bone, as well as generalised hyperostosis and a tendency to form post-operative heterotopic new bone [1] .
DISH is a systemic condition and not just the result of local mechanical factors present in each of the involved areas of the skeleton. Since the early descriptions of DISH there have been associations with a variety of metabolic factors. Many of these have subsequently been further studied to better define any associations between a particular metabolic factor and DISH. In this report we review the available literature on a number of the putative metabolic factors that have been studied in patients with DISH. Our aim was to identify associations between such factors and DISH in order to better focus future research in this area.
METHODS
Papers discussed in this review were identified from the authors' own databases and were supplemented with searches on PubMed and online journals. The following keywords were used in various combinations: "diffuse *Address correspondence to this author at the Suite H, Monash Medical Centre, 246 Clayton Road, Clayton, Victoria, 3168, Australia; Tel: 613 95942575; Fax: 613 95945588; E-mail: geoff.littlejohn@monash.edu idiopathic skeletal hyperostosis", "ankylosing hyperostosis", "Forestier's disease", "diabetes", "insulin", "obesity", "metabolic", "growth factors", "adipokines", "glucose tolerance" and "chondrocytes". The bibliography of relevant identified papers was scanned and information from abstracts and non-English sources was included as deemed relevant. The derived information is presented in summary form. Differences in patient identification and other methodology varied to the degree that formal systematic review was not valid.
The anatomical, radiological and clinical features of DISH have been described under various names for over 150 years. These studies also use different definitions for the diagnosis of DISH. These range from hyperostosis linking two vertebral bodies, without intervening disc disease and extend to different numbers of vertebrae linked by confluent anterior longitudinal ligament related new bone. The different criteria used are summarised in Table 1 . In this review we have included studies using different criteria in order to maximize any associations with putative metabolic factors.
Obesity and DISH
In the defining paper of Forestier and Rotes-Querol it was noted that six of the nine males described with DISH, then termed ankylosing hyperostosis, were stated to be obese [11] . Other subsequent studies have also noted this association.
A series of paleopathological studies is summarized in Table 2 . These studies show that there is a significant difference in the prevalence of DISH between groups with different social status, with specific material from monastic and high-status burial sites being more affected by DISH than remains from laymen burials [12] . The proposition is that the higher social status groups were excessively nourished, with probable increased rates of obesity, compared to the poorer laymen [8] . It is noted that these studies vary in their criteria for defining DISH and that different definitions result in different rates of diagnosis in the same populations [12] . Nevertheless, it is the differences between rates of DISH in the higher and lower social status classes that imply an association between DISH and nutritional factors, particularly those relating to obesity.
In one study the prevalence of DISH in skeletons from cemeteries in churches and chapels, serving priests, monks and lay benefactors, was compared to lay cemeteries in adjacent regions serving the general population [8] . By combining data from the Wells Cathedral and the Royal Mint sites, the authors found that skeletons deemed to derive from high social status individuals had a significantly higher prevalence of DISH compared to those deemed to be of lower social status (P<0.001). The diet of high social status individuals, such as those living in mediaeval monasteries, was high in animal fat and alcohol [8] . A diet rich in animal fat and alcohol and low in vegetables and fruit has been detailed in members of the Medici family found to have DISH [13] .
These findings are consistent across many regions and in different countries even when variations of criteria for diagnosis of DISH are used.
More contemporary clinical data on associations between DISH and obesity are presented in Table 3 .
Many of these studies are observational and of historical interest, with no appropriate comparator group. Schilling et al. found higher levels of obesity in patients with DISH compared to controls [24] . Additionally, Julkunen et al. found a significant association between DISH and obesity in a large population survey in Finland [3] . DISH patients had a higher weight -height index compared to controls without DISH, particularly in those over the age of sixty.
An age and sex-matched comparative study of patients with DISH and those with spondylosis showed a significantly higher body mass index [BMI] in the DISH Bywaters [2] Complete bridge between 2 vertebral bodies with normal intervening disc. Describes a minimal / inadequate criteria set.
Julkunen [3] Lateral thoracic spine x-ray showing "two typical hyperostotic bridges". Radiological criteria for epidemiological purposes.
Harris [4] Hypertrophic bony spurs with at least 2 bony bridges, normal sacro-iliac joints Excluded changes associated with other identifiable spinal disease
Resnick and Niwayama [5] Bridging of four contiguous vertebral bodies, minimal intervertebral disc disease, no facet joint ankylosis and no sacro-iliac joint inflammatory changes.
Most widely used criteria, does not include extra-spinal changes.
Arlet and Maziéres [6] Bridging of three contiguous vertebral bodies located in lower thoracic region, minimal intervertebral disc disease, no facet joint ankylosis no intra-articular erosion or ossification of sacro-iliac joints.
"Possible DISH" allowed with variations of criteria allowed.
Utsinger [7] Bridging of four contiguous vertebral bodies primarily in thoracolumbar spine, minimal intervertebral disc disease, no facet joint ankylosis.
'Probable DISH" if bridging of two contiguous vertebral bodies plus bilateral patellar tufting, heel spurring and olecranon tufting.
"Possible DISH" if two vertebrae joined in absence of extra-spinal enthesophytes or symmetrical extra-spinal enthesophytes in absence of spinal involvement.
Rogers and Waldron [8] Ossification of anterior longitudinal ligament affecting 3 vertebrae (with/without) ankylosis, confined to right side of thoracic spine, evidence of symmetrical extra-spinal DISH, including patellar tufting, heel spurring, olecranon tufting, ossification of ligamentum flavum and spurring of tibial tuberosities. Lack of intervertebral changes not required for diagnosis.
Criteria used in paleopathological health assessments.
Maat et al. [9] Spinal ligament ossifications of four or more contiguous vertebral levels and/or extensive peripheral enthesopathies Criteria used in paleopathological health assessments.
Crubézy [10] Bridging of two intervertebral spaces at the lower thoracic spine or bridging of three intervertebral spaces at any level. Decreased disc height in elderly subjects and para-articular bony bridging of the sacroiliac joints do not rule out the diagnosis Probable DISH if flowing ossification along the anterolateral aspect of at least two contiguous vertebras and enthesopathies without remodeling of the cortex symmetrically involving the posterior calcanei, olecranons, and upper patellae.
*Various authors.
group and as well a higher weight at the age of 25 years in the DISH group (all p<0.001) [25] .
Mader et al. found significantly higher waist circumference, a marker of obesity and metabolic syndrome [26] , in both men and women with DISH [27] . The BMI was statistically higher in both the men and women with DISH compared to the controls and the percentage of DISH patients with BMI above 30, indicating obesity, was also significantly higher.
In a review of patients with psoriatic arthritis [PsA] from the one cohort [28] , 78 patients were identified with DISH using the spinal criteria of Utsinger [7] . These patients were compared to 234 PsA patients without DISH from the same cohort. There was a significant increase in BMI in the PsA patients with DISH compared to those with PsA without DISH. Obesity rates were higher in the PsA patients without DISH [mean ± standard deviation = 50 ± 33.8 versus the PsA plus DISH group [31 ± 70.5] . The very high variance in the data makes interpretation of the association of DISH and obesity in this population unclear, although the BMI was significantly elevated.
Diabetes and DISH
Overlapping and subsequent studies have focussed on the association between DISH and altered glucose tolerance and adult onset Type 2 diabetes mellitus. These studies have The studies seeking association between DISH and glucose intolerance and/or diabetes have addressed the issue in two ways. Firstly, studies have looked for abnormalities of glucose intolerance in patients defined as having DISH. These are summarized in Table 4 .
In a Finnish study Julkunen [3] found a significant difference between the rates of hyperglycaemia in patients with and without DISH [p<0.05]. Hyperglycaemia, was defined as >250mg/100ml one hour after an oral glucose tolerance test or the presence of established diabetes. Analyses of intercorrelations between glucose tolerance and obesity in this series suggested that decreased glucose tolerance and obesity contributed at least in part to DISH, independently of each other.
Mader found higher fasting glucose levels in DISH patients compared to controls but many in each group were diabetic and medication was not taken into account. Overall these studies are very suggestive of an increased rate of Type 2 diabetes and/or impaired glucose tolerance in patients with diagnosed DISH, although there is marked inconsistency in diagnosis of DISH, selection of controls and definitions used to define diabetes and impaired glucose tolerance.
Another series of studies have sought to assess the rates of DISH in patients with abnormal glucose tolerance or diabetes. These studies also vary significantly with respect to diagnostic criteria and study design and are summarized in Table 5 .
Although the quality of these studies varies, there is a general theme indicating that there is an excess prevalence of DISH in patients with diabetes or abnormal glucose tolerance compared to those with normal glucose tolerance. There is an increased prevalence of DISH in diabetic patients recruited from hospital clinics, likely reflecting bias due to comorbidity factors [57] . However, when non-diabetics, aged 60 -69 years, were compared to diabetics of the same age the prevalence of DISH increased from 4% to 21% [p<0.001] [58] .
Additionally, glucose intolerance and obesity seem to act as independent risk factors in their association with DISH [3] . There has been no relationship found between the degree of hyperglycaemia and the severity of the bony change in DISH [48] . Importantly no patient with juvenile onset, i.e., Type 1 [primary insulin deficient] diabetes has been recorded as having DISH.
Growth Hormone and Related Hormones and DISH
It has been proposed that growth hormone or related hormones may be involved in the new bone growth, and also the increased rates of diabetes, that characterize DISH. Table  6 summarizes selected studies of growth hormone and related peptides in patients with DISH. Growth hormone measured in one study, both after an overnight fast and after a glucose challenge, showed no difference between DISH patients and weight-matched controls [61] . In contrast, in a study that involved DISH subjects that were significantly heavier than the controls the basal growth hormone was also significantly higher [62] . IGF-1 levels were not different to controls. In this study basal insulin was also significantly elevated. Overall, however there is no conclusive data to indicate elevation of growth hormone or Insulin-like growth factor in patients with DISH.
Insulin and Related Hormones and DISH
Insulin is elevated in Type 2 diabetes mellitus and is a bone growth promoting peptide [69] . Various studies seeking associations of these hormones with DISH are summarized in Table 7 .
Insulin, measured both after an overnight fast and after a glucose challenge, showed significant elevation in DISH patients compared to weight and BMI-matched controls [p<0.001] [61] . The change in insulin was noted despite no significant change in blood glucose levels, either at base-line or after glucose stimulation. Insulin levels, measured 2 hours after glucose challenge showed highly significant correlation to BMI in the DISH group. Some studies support this finding [68] , while others (as outlined in Table 7 ) do not.
The fact that insulin levels correlate with being overweight [55, 60, 68, 70 ] is a potential confounder in these studies.
Adipokines
The increased rates of obesity, particularly abdominal fat, in patients with DISH might imply a role for various adipokines in the pathogenesis of this disorder. Many of these fat-derived cytokine-like hormones have significant effects on bone metabolism [71] .
Leptin is encoded in the obese gene, secreted by adipose tissues and involved in maintenance of weight. Leptin has effects on bone in mice promoting osteoblast numbers and activity through peripheral pathways [72] . In humans leptin levels associate with increase cortical but not cancellous bone [73] . Hereditary obese rats [Zucker fatty (fa/fa) rats] have an aberration of the leptin receptor gene and develop ossification of spinal ligaments [OSL], a condition with similarities to DISH that targets the posterior longitudinal spinal ligament [74] . Japanese female patients with OSL, but not males have elevated leptin, which correlates with elevated insulin levels [74] . There is a positive correlation with extent and severity of ligamentous ossification in OSL [75] . The leptin receptor is expressed in human spinal ligaments, although in vitro studies did not show increased collagen synthesis after exposure to leptin [74] . Both leptin and its receptor are also expressed in the annulus, increasing with advanced age [76] . Leptin is found in high levels in osteophytes of patients with osteoarthritis [77] . Leptin has not been specifically studied in DISH but the studies in the related ossifying disorder of OSL are shown in Table 8 . Leptin levels were significantly elevated in females with OSL in this study. In 37 patients with DISH the serum levels of the osteoblast inhibitor Dickkopf-related protein-1 [DKK-1] were significantly lower compared to 22 healthy, agematched controls. Lower levels associated with more spinal hyperostosis independent of age, sex, bone-turnover markers or bone mineral density [78] . However, another study did not find an association between DKK-1 and DISH [79] making this observation difficult to interpret.
BONE REGULATORY PROTEINS

Co-Morbid Metabolic Factors
Patients with DISH have significant associations with gout, hyperuricemia and dyslipidaemia, likely through the shared association with obesity [27, 55, [80] [81] [82] [83] [84] . There is no evidence that these factors in their own right cause the new bone formation characteristic of DISH Vitamin A Vitamin A -related products can cause hyperostosis in animals and man [85, 86] . Vitamin A has been shown to be elevated in patients with DISH [87] but it remains unclear as to the exact role of Vitamin A in DISH.
Animal Models
DISH has been described in numerous animal species but there are no well-designed animal experiments to demonstrate the causal relationship between metabolic factors and DISH [88, 89] . 
Metabolic Factors and Targets in DISH
The metabolic factors present in patients with DISH, such as insulin, likely interact with key candidate cellular targets linking to new bone formation. These include chondrocytes and periosteal mesenchymal cells within the enthesis [90, 91] (See Fig. 1 ). These cells have been shown to proliferate under the influence of transforming growth factor-β1, insulin and bone morphogenic protein (BMP2) to form fibroblasts, myoblasts and osteoblasts [91] . Metabolic factors, such as insulin, growth hormone and insulin-like growth factor 1, all have the ability to promote bone formation through stimulation of proliferation of osteoblasts, chondrocytes and fibroblasts [82, 84] . The exact mechanisms that contribute to the new bone growth, particularly in entheseal regions, in patients with DISH are unknown. However, relevant important signalling pathways are likely to include the Wnt -β-catenin pathway, nuclear factor κB, BMP2, prostaglandin I2 and endothelin1 [92] .
FUTURE STUDIES
There is a need for further studies to better define the important background metabolic factors that promote the new bone formation that characterizes DISH. These need to include a group of interacting factors, including genetic, epigenetic, metabolic and bone-related signalling pathways. Study of younger patients with early DISH may better identify important metabolic factors but this approach is limited by current diagnostic criteria that identify wellestablished DISH, with high rates of confounding comorbidities [93] . It is important for future studies to incorporate direct examination of the cellular elements of the key target organ of DISH, the enthesis.
SUMMARY
This review examines the available literature on metabolic factors in patients with DISH. The identified literature was not considered robust enough to perform a structured systematic review due to inconsistencies with study methodologies. These include different criteria for diagnosis of DISH, and different definitions for diabetes, and impaired glucose tolerance. Metabolic studies varied in the protocols used, with different time frames and stimulation protocols. Controls were often lacking or poorly matched for metabolic factors. We have commented on these issues in the summary tables. Nevertheless we aimed to make this review a contemporary summary on the topic to act as a reference standard for future studies.
Despite the above comments this review of metabolic factors in DISH does allow for certain conclusions. There is a general theme that metabolic factors are of great importance in DISH. Obesity, particularly abdominal obesity, is strongly linked to DISH. Further exploration of the role adipokines in patients with DISH is required. Type 2 diabetes is increased in DISH, independent of obesity. The link between obesity, type 2 diabetes and insulin elevation is strong. Of all the potential growth factors examined in patients with DISH, insulin is likely to have a key role in the pathophysiology of DISH.
Finally, it is clear that more studies are required on this important aspect of DISH, a condition that is increasing in frequency and significance.
